Dynavax Technologies Corporation (NASDAQ: DVAX) stock closed at 9.96 per share at the end of the most recent trading day (a 0.91% change compared to the prior day closing price) with a volume of 1.20M shares and market capitalization of 1.26B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 245 people. Dynavax Technologies Corporation CEO is Ryan Spencer.

The one-year performance of Dynavax Technologies Corporation stock is -13.84%, while year-to-date (YTD) performance is -6.39%. DVAX stock has a five-year performance of -46.16%. Its 52-week range is between 7.26 and 17.48, which gives DVAX stock a 52-week price range ratio of 25.44%

Dynavax Technologies Corporation currently has a PE ratio of 4.60, a price-to-book (PB) ratio of 2.69, a price-to-sale (PS) ratio of 2.43, a price to cashflow ratio of 11.40, a PEG ratio of 2.32, a ROA of 36.02%, a ROC of 59.68% and a ROE of 114.85%. The company’s profit margin is 41.89%, its EBITDA margin is 46.40%, and its revenue ttm is $538.19 Million , which makes it $4.22 revenue per share.

Of the last four earnings reports from Dynavax Technologies Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.12 for the next earnings report. Dynavax Technologies Corporation’s next earnings report date is 04th May 2023.

The consensus rating of Wall Street analysts for Dynavax Technologies Corporation is Strong Buy (1), with a target price of $24, which is +142.18% compared to the current price. The earnings rating for Dynavax Technologies Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Dynavax Technologies Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Dynavax Technologies Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 23.10, ATR14 : 0.34, CCI20 : -34.81, Chaikin Money Flow : -0.14, MACD : -0.33, Money Flow Index : 31.12, ROC : -4.60, RSI : 43.01, STOCH (14,3) : 48.21, STOCH RSI : 1.00, UO : 58.53, Williams %R : -51.79), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Dynavax Technologies Corporation in the last 12-months were: Andrew A. F. Hack (Sold 4 500 000 shares of value $61 440 000 ), David Novack (Option Excercise at a value of $0), David Novack (Sold 98 454 shares of value $1 415 021 ), Francis R. Cano (Option Excercise at a value of $74 550), Francis R. Cano (Sold 15 000 shares of value $257 550 ), Justin Burgess (Option Excercise at a value of $133 920), Justin Burgess (Sold 53 043 shares of value $664 342 ), Kelly MacDonald (Option Excercise at a value of $0), Robert Janssen (Option Excercise at a value of $65 438), Robert Janssen (Sold 22 126 shares of value $375 541 ), Ryan Spencer (Option Excercise at a value of $0), Ryan Spencer (Sold 14 921 shares of value $252 399 )